ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1662

Nationwide Distribution of Other Connective Tissue Disease (OCTD) and Systemic Sclerosis (SSc) in Areas of Environmental Concern

Noelle Kosarek1, Megan Romano2, Robert Simms3, Angeline Andrew4, Erika Moen4, Patricia pioli4 and Michael Whitfield5, 1Dartmouth Geisel School of Medicine, Lebanon, NH, 2Dartmouth College, Lebanon, NH, 3Dartmouth Hitchcock Medical Center, Lebanon, NH, 4Geisel School of Medicine at Dartmouth, Lebanon, NH, 5Dartmouth Geisel School of Medicine, Department of Biomedical Data Science, Lebanon, NH

Meeting: ACR Convergence 2022

Keywords: autoimmune diseases, Epidemiology, Scleroderma, Scleroderma, Systemic, skin

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 14, 2022

Title: Abstracts: Systemic Sclerosis and Related Disorders – Clinical II: Clinical Phenotypes

Session Type: Abstract Session

Session Time: 9:00AM-10:30AM

Background/Purpose: Systemic sclerosis (SSc) is a rare autoimmune disease characterized by fibrosis of the skin and internal organs, vascular abnormalities, and autoantibody formation. The etiology of SSc is unknown, but it is thought to arise in genetically predisposed individuals after exposure to an environmental factor. Occupational, bacterial, and viral factors including silica dust, Rhodotorula glutinis, and Epstein Barr virus, have been cited as potential environmental triggers of SSc. We hypothesized that SSc exhibits a non-random geographic distribution in a US Medicare beneficiary cohort between 2014 and 2018.

Methods: We selected beneficiaries from the US Medicare database that had diagnosis codes associated with SSc and other connective tissue disease (OCTD). We calculated incidence rates for SSc and OCTD in each zip code in the United States. Using ArcGIS we plotted the incidence of OCTD and SSc and conducted global and local Moran’s I spatial autocorrelation to identify potential clusters of disease. We also executed optimized hot spot analysis, which utilizes the Getis-Ord Gi statistic, to evaluate statistically significant hot and cold spots.

Results: Our study population consisted of 207,467 OCTD beneficiaries between the years 2014 and 2018. Our cohort is 68.2% female and 86.8% White. 29.8% of the beneficiaries in our cohort resided in the Southeastern US. Of the 207,467 OCTD beneficiaries, 55,696 are characterized as SSc beneficiaries. The SSc specific beneficiary cohort is 67.7% female, 83.3% White and most beneficiaries in the Southeastern US between 2014 and 2018. We found statistically significant clusters of OCTD and SSc across the United States using spatial autocorrelation (Figure 1). The Moran’s I for our OCTD global spatial autocorrelation is 0.05 with a z-score of 48.2 and a p-value of 0.00. The Moran’s I for our SSc specific global spatial autocorrelation is 0.35 with a z-score of 25.1 and a p-value of 0.00. Examples of specific clusters found in Wisconsin, Michigan, Ohio, New York, Georgia, Mississippi, and New Jersey are shown. We overlaid statistically significant clusters with superfund sites and found that several of these clusters occurred in zip codes containing at least one superfund site. Examples of clusters with co-location of superfund sites include Mississippi, New York, Wisconsin, and New Jersey. Notably, several of these locations are former wood preserving sites. We accessed contaminant information at these sites through the Environmental Protection Agency (EPA) website and compiled a list of potential OCTD and SSc inducing exposures. These contaminants include vinyl chloride, 1,2 dichloroethane, and other volatile organic compounds.

Conclusion: We identified statistically significant clusters of OCTD and SSc in the United States. Many of these hot spots are concentrated around areas of environmental contamination. Concentrated studies at these locations are necessary to describe the complexity of these cases.

Supporting image 1

Figure 1: Distribution of the incidence rate of Medicare beneficiaries carrying a diagnosis of OCTD or SSc by zip code between the years 2014 and 2018. We noted statistically significant clusters in Wisconsin, Michigan, Ohio, New York, Georgia, and Mississippi.


Disclosures: N. Kosarek, None; M. Romano, None; R. Simms, None; A. Andrew, Boston Scientific; E. Moen, None; P. pioli, None; M. Whitfield, Corbus Pharmaceuticals, Celdara Medical LLC, Bristol-Myers Squibb(BMS).

To cite this abstract in AMA style:

Kosarek N, Romano M, Simms R, Andrew A, Moen E, pioli P, Whitfield M. Nationwide Distribution of Other Connective Tissue Disease (OCTD) and Systemic Sclerosis (SSc) in Areas of Environmental Concern [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/nationwide-distribution-of-other-connective-tissue-disease-octd-and-systemic-sclerosis-ssc-in-areas-of-environmental-concern/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/nationwide-distribution-of-other-connective-tissue-disease-octd-and-systemic-sclerosis-ssc-in-areas-of-environmental-concern/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology